$46.80
1.21% yesterday
NYSE, Oct 03, 10:00 pm CET

QIAGEN NV Stock price

$46.80
+0.10 0.21% 1M
+6.43 15.93% 6M
+1.00 2.18% YTD
+2.02 4.50% 1Y
+2.25 5.06% 3Y
-9.61 17.04% 5Y
+17.37 59.00% 10Y
+32.45 226.17% 20Y
NYSE, Closing price Fri, Oct 03 2025
+0.56 1.21%

Key metrics

Basic
Market capitalization
$10.1b
Enterprise Value
$10.6b
Net debt
$490.2m
Cash
$953.8m
Shares outstanding
216.8m
Valuation (TTM | estimate)
P/E
27.5 | 19.4
P/S
5.0 | 4.8
EV/Sales
5.2 | 5.0
EV/FCF
21.4
P/B
2.9
Dividends
DPS
$1.55
Yield 1Y | 5Y
3.3% | 1.2%
Growth 1Y | 5Y
13.9% | -
Payout 1Y | 3Y
357.2% | 35.6%
Increased
2 Years
Financials (TTM | estimate)
Revenue
$2.0b | $2.1b
EBITDA
$555.7m | $787.8m
EBIT
$547.9m | $604.3m
Net Income
$373.4m | $523.3m
Free Cash Flow
$496.0m
Growth (TTM | estimate)
Revenue
5.2% | 7.4%
EBITDA
20.6% | 56.1%
EBIT
21.8% | 22.1%
Net Income
413.6% | 526.0%
Free Cash Flow
22.4%
Margin (TTM | estimate)
Gross
64.2%
EBITDA
27.2% | 37.1%
EBIT
26.9%
Net
18.3% | 24.6%
Free Cash Flow
24.3%
Financial Health
Equity Ratio
62.7%
Return on Equity
2.3%
ROCE
11.7%
ROIC
8.9%
Debt/Equity
0.4
More
EPS
$1.7
FCF per Share
$2.3
Short interest
4.6%
Employees
5k
Rev per Employee
$380.0k
Show more

Is QIAGEN NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

QIAGEN NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a QIAGEN NV forecast:

12x Buy
50%
12x Hold
50%

Analyst Opinions

24 Analysts have issued a QIAGEN NV forecast:

Buy
50%
Hold
50%

Financial data from QIAGEN NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,040 2,040
5% 5%
100%
- Direct Costs 731 731
2% 2%
36%
1,309 1,309
7% 7%
64%
- Selling and Administrative Expenses 569 569
0% 0%
28%
- Research and Development Expense 185 185
5% 5%
9%
556 556
21% 21%
27%
- Depreciation and Amortization 7.77 7.77
28% 28%
0%
EBIT (Operating Income) EBIT 548 548
22% 22%
27%
Net Profit 373 373
414% 414%
18%

In millions USD.

Don't miss a Thing! We will send you all news about QIAGEN NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

QIAGEN NV Stock News

Neutral
Seeking Alpha
9 days ago
Qiagen N.V. (NYSE:QGEN ) Bank of America Global Healthcare Conference 2025 September 25, 2025 5:45 AM EDT Company Participants John Gilardi - VP & Head of Corporate Communications Conference Call Participants Michael Ryskin - BofA Securities, Research Division Presentation Michael Ryskin BofA Securities, Research Division Thanks for joining us.
Neutral
Business Wire
24 days ago
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has achieved CE-IVDR certification for its full portfolio of QIAstat-Dx syndromic testing systems and panels, including an expanded Meningitis/Encephalitis (ME) Panel that sets a new benchmark in the diagnosis of central nervous system (CNS) infections. The QIAstat-D...
Neutral
Seeking Alpha
24 days ago
Qiagen N.V. (NYSE:QGEN ) Baird Global Healthcare Conference 2025 September 10, 2025 1:25 PM EDT Company Participants Roland Sackers - CFO, MD & Member of Management Board John Gilardi - VP & Head of Corporate Communications Presentation Unknown Analyst Diagnostics here at Baird.
More QIAGEN NV News

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Head office Netherlands
CEO Thierry Bernard
Employees 5,232
Founded 1996
Website www.qiagen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today